Compare Mitsubishi UFJ Financial Group Inc. Common Stock (MUFG) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitsubishi UFJ Financial Group Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Mitsubishi UFJ Financial Group Inc. Common Stock trades at $22.31 (market cap $249.48B), while Roivant Sciences Ltd. Common Shares trades at $35.08 (market cap $24.72B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 10.1× Roivant Sciences Ltd. Common Shares's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.4% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mitsubishi UFJ Financial Group Inc. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| MUFG | ROIV | |
|---|---|---|
Market Cap | $249.48B | $24.72B |
Volume | 4,008,160 | 6,279,442 |
Sector | Financials | Health |
52-Week High | $24.13 | $41.81 |
52-Week Low | $14.62 | $16.04 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $28.96T | $20.99B |
Dividend Yield | 2.4% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mitsubishi UFJ Financial Group Inc. Common Stock
Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
